Actinidia polygama Max. was subjected to supercritical fluid extraction (SFE), and the resulting ethanol extract of marc (SFEM) was subjected to sequential fractionation with various solvents. Each extract and fraction was assayed for anti-inflammatory effect. The ethyl acetate fraction (EtOAc) contained the highest level (70.8% inhibition) of anti-inflammatory activity. In order to identify the active constituents, the EtOAc fraction was further fractionated by silica gel and ODS column chromatography. By activity-guided fractionation, an active ceramide was identified as the antiinflammatory component, and its structure was determined by NMR and MS analysis. The novel ceramide was named actinidiamide, and was found significantly to inhibit nitric oxide (NO) production (30.6% inhibition at 1 g/mL) in lipopolysaccaride (LPS)-stimulated RAW 264.7 cells and -hexosaminidase release (91.8% inhibition at 1 g/mL) in IgE-sensitized RBL-2H3 cells. Thus the presence of actinidiamide conveys allergy and inflammation treatment ability to A. polygama.
Actinidia polygama Max. (silver vine) is used as a folk medicine in Korea for treating pain, gout, and inflammation. Only a few studies have provided detailed information on the medicinal effects of A. polygama fructus extracts. A water extract of A. polygama suppressed rat paw edema induced by carrageenan, inhibited the production of nitric oxide (NO) induced by lipopolysaccharide (LPS), and inhibited the expression of inducible NO synthase (iNOS) protein in RAW 264.7 macrophages. 1) Additionally, it demonstrated anti-asthmatic effects in a murine model of asthma.
2) Recently, -linoleic acid was identified as an active component of A. polygama fruits. It strongly inhibits NO production, iNOS, cyclooxygenase (COX)-2, and tumor necrosis factor (TNF)-expression by blocking the activation of nuclear factor kappa (NF-k) B and mitogen-activated protein kinases (MAPKs) in LPS-activated RAW 246.7 cells.
3) Moreover, it inhibited the vascular permeability induced by acetic acid and the edema induced by carrageenan in mouse and rat.
3) It is not clear, however, whether -linoleic acid is the main component responsible for reducing inflammation and allergic reactions.
iNOS can be induced to produce NO by bacterial LPS or immunological stimuli such as interferon (IFN)-, and sustained NO synthesis mediates inflammatory reactions in macrophages and other cells. Macrophages play a major role in innate immunity, initiating and propagating defensive reactions against pathogens. Excess NO production by macrophages and other cells exposed to endotoxins can contribute to cerebral injury, 4) myocardial ischemia, 5) inflammatory disorders, diabetes and other diseases. [6] [7] [8] Although iNOS activation is not a major event in all of these diseases, the proinflammatory effects of NO generated by iNOS contribute to pathophysiology in each case. Therefore, inhibiting NO synthesis is potentially beneficial in preventing inflammatory reactions. The murine macrophage-like cell line RAW 264.7 has previously been used to characterize the actions of various immunomodulatory compounds at the molecular level. [9] [10] [11] Mast cells are distributed throughout the body and play a primary role in acute inflammation and allergic responses. 12, 13) They are also important in mediating the inflammatory response in allergic reactions by producing cytokines, including IL-4, IL-5, IL-6, and TNF-.
14)
The rat basophilic leukemia cell line RBL-2H3 is a mucosal mast cell line, and is the major model system for antigen-induced degranulation. 15) Several studies have shown that allergic inflammation mediated by mast cells is suppressed by phenolics or flavonoids, such as rutin and chlorogenic acid, 16) EGCG, 17) paeonol, 18) fisetin, kaempferol, myricetin, quercetin, rutin, 19) and morin. 20) Supercritical fluid extraction (SFE) is used to improve the flavor of A. polygama. We investigated the antiallergic effects of the ethanol extract of marc (SFEM), which results from SFE. 21) Our aim was to isolate the constituent in the ethanol extract with the greatest antiinflammatory activity and to determine its structure.
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Materials and Methods
Plant sample. Dried fruit of A. polygama was purchased from a Chinese drug store in Yeongcheon City, Gyeongbuk, Korea. A voucher specimen (KHU-090723) was deposited at the Laboratory of Natural Products Chemistry, Kyung Hee University, Yongin, Korea.
Instruments and reagents. Melting points were determined using a Fisher-John apparatus (Fisher Scientific, Pittsburgh, PA) and were not corrected. Optical rotation was measured on a Jasco P-1010 digital polarimeter (Jasco, Tokyo). The IR spectrum was collected on a Perkin-Elmer Spectrum One FT-IR Spectrometer (Perkin-Elmer, Norwalk, CT). EIMS was recorded on a JEOL JMS 700 (JEOL, Tokyo).
1 H NMR (400 MHz) and 13 C NMR (100 MHz) spectra were assessed using a Varian Unity Inova AS 400 FT-NMR spectrometer (Palo Alto, CA). CHCl 3 -d 1 with TMS as internal standard was purchased from Sigma (St. Louis, MO). Dinitrophenyl (DNP)-specific IgE, Earle's basal salt solution (EBSS), trypsin solution, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), and LPS were from Sigma (Sigma, St. Louis, MO). Fetal bovine serum (FBS), minimal essential medium (MEM), and other cell culture reagents were from Gibco BRL (Grand Island, NY). DNP-bovine serum albumin was from Alpha Diagnostic International (San Antonio, TX). All other reagents were from Sigma Aldrich (St. Louis, MO).
Preparation of crude extract, marc of the supercritical fluid extract, and ethanol extract of it from A. polygama. One kg of dried A. polygama was ground and extracted 3 times with a 10-fold excess w/v of 70% ethanol at room temperature over 24 h. After filtering of the extract solutions, the combined filtrate was concentrated by rotary vacuum evaporator (Eyela Uni Trap UT-1000, Tokyo, Japan) at 55 C and freeze-dried to use as the ethanol extract of A. polygama (EtOH, 306.9 g). Essential oils from A. polygama were extracted using the SFE apparatus (SFT-100XW, Supercritical Fluid Technologies, Newark, DE). Briefly, 40 g of A. polygama were placed in an extraction vessel (100 mL), and SFE was statically conducted with supercritical CO 2 (flow rate, 2.0 mL/min) at 4,500 psi at 45 C for 1 h. The remaining marc was extracted 3 times with a 10-fold excess w/v of 70% ethanol at room temperature over 24 h. The ethanol extract was concentrated as described above and freeze-dried as the ethanol extract of SFEM (7.6 g).
Separation of the active compound from A. polygama. The SFEM of A. polygama (5 kg) was extracted with 80% methanol (34 L) at room temperature over 17 h. The concentrated extract was successively partitioned with water (2.5 L), EtOAc (2 L Â 2), and n-butanol (2 L Â 2) to yield an H 2 O extract (562 g, APW), an EtOAc extract (580 g, APE), and an n-BuOH extract (138 g, APB). The EtOAc extract was fractionated with silica gel (70-230 mesh) column chromatography (c.c. 10 Â 17 cm), and eluted with CHCl 3 -MeOH (10:1 ! 8:1 ! 6:1 ! 4:1 ! 2:1 ! 1:1, each 2 L). The eluate was collected in 15 fractions (APE-1 to APE-15) monitored by thin layer chromatography (TLC). All the 10 g collected as fraction APE-9 (Ve/Vt ¼ 0:35) was subjected to silica gel c.c. (4 Â 18 cm) eluted with n-hexane-EtOAc (2:1, 1.5 L). The eluate was collected in 13 fractions (APE-9-1 to APE-9-13). The APE-9-11 (Ve/Vt ¼ 0:25, 290 mg) fraction was subjected to ODS c.c. (3 Â 10 cm) eluted with MeOH-H 2 O (2:1, 1.5 L) to produce purified compound 1 (APE-9-11-21, Ve/Vt ¼ 0:51, TLC(RP-18 F254s)
Cell culture. RAW 264.7 cells, a murine macrophage cell line, and RBL-2H3 cells, a rat basophilic leukemia cell line, were purchased from the Korean Cell Line Bank (KCLB, Seoul, Korea). RAW 264.7 cells were cultured in DMEM (Gibco-BRL, Rockville, MD) containing 1% antibiotics (penicillin/streptomycin) and 10% heat-inactivated FBS (Gibco). RBL-2H3 cells were grown in MEM (Gibco) with 10% FBS and 1% penicillin/streptomycin. Both cell lines were grown in a 37 C humidified incubator with 5% CO 2 in air.
Determination of cell viability. To determine the cytotoxicity of the A. polygama extract, cell viability was determined by MTT assay, 22) in which active mitochondria reduce MTT into formazan dye. RBL-2H3 cells were seeded at a density of 3 Â 10 4 cells/well in 96-well microplates. The next day, the cells were treated with various concentrations (0, 100, 200, and 400 mg/mL) of A. polygama extract at 37 C. After 48 h, 100 mL of MTT (5 mg/mL) was added to each well, and the plates were incubated at 37 C for 4 h. One hundred mL of DMSO was added to each well to dissolve the cells. The plates were kept at room temperature for 5 min, and the absorbance was measured at 550 nm using a multiwell spectrophotometer (Molecular Devices, Sunnyvale, CA). The cytotoxicity of the extract in the IgEsensitized RBL-2H3 cells was also assessed by MTT assay. The cells (3 Â 10 4 cells/well) were seeded and incubated with 450 ng/mL of DNP-specific IgE at 37 C overnight before treatment with the extract.
Determination of LPS-induced NO production from RAW 264.7 cells. RAW 264.7 cells were seeded in 96-well plates (1 Â 10 5 cells/well) overnight and treated with various concentrations of test samples (in 0.1% DMSO) in the presence of LPS (final concentration, 100 ng/mL) at 37 C for 24 h. After LPS stimulation for 24 h, NO production in the cell culture medium was measured by the Griess Reagent System. 23) Briefly, the culture supernatant (100 mL) was mixed with same volume of Griess reagent (1% sulfanilamide and 0.1% naphtylethylendiamine in 2.5% phosphoric acid) for 10 min, and the absorbance was measured at 540 nm. The NO concentration was calculated from a standard curve of NaNO 2 .
Determination of antigen-induced -hexosaminidase release from RBL-2H3 cells. The inhibitory effect of the extract on the release of -hexosaminidase in the RBL-2H3 cells was evaluated as reported by Matsuda et al., 24) with modifications. In brief, RBL-2H3 cells seeded in 24-well plates (2 Â 10 5 cells/well) were sensitized with anti-DNP IgE (450 ng/mL) at 37 C overnight. The cells were washed with Siraganian buffer and then incubated in 160 mL of the incubation buffer at 37 C for 20 min. Then the cells were treated with 20 mL of extract for 10 min, followed by the addition of 20 mL of antigen (DNP-BSA, 10 mg/mL) at 37 C for 10 min to stimulate the cells to granulate. The reaction was stopped by cooling in an ice bath for 10 min. Twentyfive mL of the supernatant was transferred into a 96-well plate and incubated with 25 mL of substrate (1 mM p-nitrophenyl-N-acetyl--Dglucosaminide) in 0.1 M citrate buffer (pH 4.5) at 37
C for 1 h. The reaction was stopped by adding 200 mL of stop solution (0.1 M Na 2 CO 3 /NaHCO 3 , pH 10.0), and the absorbance was measured at 405 nm using a microplate reader. The extract was dissolved in 0.1% DMSO and added to the incubation buffer.
Statistical analysis. All experiments were performed 3-5 times. Data were expressed as mean AE standard error of the mean (SEM) or standard deviation (SD). A significant difference from the control for each experimental test condition was assessed by Student's t-test for each paired experiment. A p-value < 0:05 was regarded as indicating statistical significance.
Results and Discussion
Inhibition of allergic inflammation by the EtOH extract and various SFEM fractions of A. polygama
To test the anti-inflammatory effects of the EtOH extract of A. polygama and various SFEM fractions, NO production and cytotoxicity were measured in unstimulated and LPS-stimulated RAW 264.7 cells. The cells were incubated with LPS (100 ng/mL) in the presence of various extracts for 24 h. As Table 1 shows, the EtOH and SFEM extracts decreased the NO concentration in the culture media to 81:0 AE 2:3% and 29:4 AE 1:5% LPSstimulated cells at 100 mg/mL, respectively. Moreover, the EtOAc fraction from SFEM markedly suppressed NO production, to 29:2 AE 4:1% LPS-stimulated cells at 25 mg/mL. This fraction had a much stronger effect than the BuOH (83:2 AE 4:7%) and H 2 O (89:1 AE 7:0%) fractions. We tested cell viability by MTT assay to ensure that the decreased NO production was not due to cell death. Neither the tested fractions nor 0.1% DMSO significantly affected cell viability under the conditions imposed.
RBL-2H3 cells were used to evaluate in vitro antiallergic activity. As a marker of RBL-2H3 cell degranulation, the release of -hexosaminidase into the cell media was measured. RBL-2H3 cells were sensitized with 450 ng/mL of DNP-specific IgE overnight before treatment with DNP-BSA antigen. Previously, we tested various conditions (DNP-specific IgE, 25-450 ng/mL; antigen, 0.01, 1, 10 mg/mL) to determine the optimal conditions for degranulation. Optimal degranulation occurred following stimulation with 450 ng/mL of IgE overnight and with 10 mg/mL of antigen for 10 min. The abilities of the various extracts to inhibit -hexosaminidase release from IgE-sensitized RBL-2H3 cells induced by DNP-BSA are shown in Table 2 . -Hexosaminidase release was significantly inhibited by the EtOH, SFEM, EtOAc, and BuOH fractions (42.4-50.3% release at 100 mg/mL). The H 2 O, fraction had weak inhibitory effect (82:2 AE 5:6% release at 100 mg/ mL). The extracts were not cytotoxic to IgE-sensitized RBL-2H3 cells, and they were not toxic to the cells not treated with IgE (data not shown).
IgE-mediated allergic reactions, such as asthma and allergic rhinitis, result from the activation of signaling pathways downstream of the IgE receptor. These signaling pathways can be activated by the antigeninduced release of -hexosaminidase, a marker of mast cell degranulation, and by various pharmacological agents. 25, 26) Histamine is released from mast cells in response to an antigen or a degranulation inducer. -Hexosaminidase is stored in secretory granules within mast cells and is released with histamine in response to an antigen. Hence -hexosaminidase is a marker for histamine release from mast cells. There are several inhibitors of -hexosaminidase release, including flavonoids, 27) diarylheptanoids, 24) sesquiterpenes, 28) anthraquinones, 29) and alkaloids.
30)
Purification and structural elucidation of an antiinflammatory compound from the EtOAc fraction of A. polygama by activity-guided fractionation
The presence of a ceramide in the EtOAc layer of the 80% methanol extract of A. polygama was confirmed by silica gel TLC. As shown in Table 1 , the EtOAc fraction exhibited the highest inhibitory activity among the fractions against NO-production in LPS-stimulated RAW 264.7 cells. Repeating the silica gel column chromatography of the ethyl acetate layer yielded purified compound 1.
Actinidiamide (1) Table 3 .
Compound 1 was isolated as a white amorphous powder from CHCl 3 -MeOH. The molecular formula of 1 was established as C 34 H 67 NO 5 (calculated 569.5019) based on its positive HRFAB-MS data for the ½M þ H þ at m=z 570.5097. The IR absorption bands at 3,321 cm À1 , 2,911 cm À1 and 1,643 cm À1 are characteristic of the hydroxyl, the amide carbonyl, and the olefinic group respectively.
The H 1 NMR spectrum in pyridine-d 5 of 1 (Table 3 ) displayed a low-field doublet at H 8.55 (1H, J ¼ 9:2 Hz, NH), two olefine methine, oxygenated, or other heteroatomized protons, and two methyl protons at H 31) The 13 C NMR (Table 3) (Fig. 1) respectively. The C=C bond configuration was determined to be trans based on the vicinal coupling constants (J 4 0 ;5 0 ¼ 16:0 Hz). These trans-geometries were also deduced from the chemical shifts of allylic carbons C-3 0 and C-6 0 (C 33.85, 33.42 respectively). 32) Further investigation of the EIMS showed important fragment ions at m=z 181 and 155, suggesting a double bond at C-4 0 . The lengths of the amide chain and the fatty alcohol were determined by EI-MS (Fig. 2) . The EI-MS of 1 showed a molecular ion at m=z 569 [M] þ . Significant fragment ions at m=z 253
þ , and 316 ½M À amide chain þ in the EI-MS indicated an amino alcohol chain of 16 carbon atoms. The relative stereochemistry of 1 at C-2, C-3, C-4, and C-2 0 was proposed to be 2S, 3S, and 4R, since the proton and carbon signals were in good agreement with natural and synthetic ceramides reported in the literature. 33 (Fig. 1) .
Inhibitory effects of actinidiamide from A. polygama on allergy and inflammation
Next we evaluated the effects of the novel ceramide actinidiamide on NO production in LPS-stimulated RAW 264.7 cells and on -hexosaminidase release in RBL-2H3 cells. Ceramides are a family of sphingolipids that have antiproliferative and proapoptotic activities, [35] [36] [37] but, their role in anti-inflammatory processes is poorly understood.
As shown in Fig. 3 , NO production was inhibited by actinidiamide (in 0.08% pyridine) in a dose-dependent manner. At a concentration of 2 mg/mL, NO production decreased to 21.7%, and actinidiamide was not cytotoxic. Pyrimidine (0.08%), used as a reference, did not affect cell viability or NO production. The inhibitory effect of actinidiamide on -hexosaminidase release is shown in Fig. 4 . Actinidiamide inhibited -hexosaminidase release in a dose-dependent manner and had a significant effect at 0.5 (31:5 AE 10:3%) and 1 mg/mL (8:2 AE 3:1%) without cytotoxicity. These results suggest that actinidiamide isolated from the EtOAc fraction of SFEM from A. polygama potently regulates allergic inflammation.
In summary, we found that the EtOAc extract of SFEM from A. polygama markedly inhibited NO pro- duction without cytotoxicity in LPS-stimulated RAW 264.7 cells. The active component of the EtOAc fraction was isolated by activity-guided fractionation steps, and was identified as the novel ceramide, actinidiamide. Moreover, actinidiamide inhibited NO production in RAW 264.7 cells (0.1-2 g/mL) and degranulation in RBL-2H3 cells induced by DNP-BSA and IgE (0.1-1 g/mL) in a dose-dependent manner. At a concentration of 1 mg/mL, actinidiamide inhibited NO production andhexosaminidase by 31 and 92% respectively. The strong inhibitory activities of actinidiamide might explain the anti-inflammatory effects of the A. polygama extract. ÃÃ p < 0:01 vs. IgE alone.
